Glucocorticoid Receptor 

 186 Products   186 Products   1696 Diseases   95004 News 


«12...174175176177178179180181182183184...10651066»
  • ||||||||||  dexamethasone / Generic mfg., dexmedetomidine / Generic mfg.
    Enrollment closed, Trial completion date, Trial primary completion date:  AADDCToR: Adjuncts for Adductor Block: Dexamethasone,Dexmedetomidine, or Combination to Reduce Pain (clinicaltrials.gov) -  Apr 26, 2023   
    P4,  N=252, Active, not recruiting, 
    Active, not recruiting --> Recruiting Suspended --> Active, not recruiting | Trial completion date: Dec 2022 --> Feb 2025 | Trial primary completion date: Dec 2022 --> Dec 2024
  • ||||||||||  Thymoglobulin (anti-thymocyte globulin (rabbit)) / Sanofi
    Enrollment closed, Trial completion date, Trial primary completion date:  ScanCLAD: Clinical Study Evaluating Two Treatment Protocols for Immunosuppressive Drugs. Looking at 3-year Incidence of CLAD. (clinicaltrials.gov) -  Apr 26, 2023   
    P=N/A,  N=249, Active, not recruiting, 
    Suspended --> Active, not recruiting | Trial completion date: Dec 2022 --> Feb 2025 | Trial primary completion date: Dec 2022 --> Dec 2024 Completed --> Active, not recruiting | Trial completion date: Oct 2022 --> Oct 2026 | Trial primary completion date: Oct 2022 --> Oct 2025
  • ||||||||||  dexamethasone / Generic mfg.
    Journal:  Dexamethasone: 3 things the general dentist needs to know. (Pubmed Central) -  Apr 25, 2023   
    Completed --> Active, not recruiting | Trial completion date: Oct 2022 --> Oct 2026 | Trial primary completion date: Oct 2022 --> Oct 2025 No abstract available
  • ||||||||||  dexamethasone / Generic mfg.
    Journal:  Short- and long-term T cell and antibody responses following Dexamethasone treatment in COVID-19. (Pubmed Central) -  Apr 25, 2023   
    Dexamethasone treatment is associated with short-term reduction of T cell and antibody response in severe COVID-19 when compared to the non-treated group, but this difference evens out six months after infection. We confirm higher cellular and humoral immune responses in patients after severe versus mild COVID-19 infection and the concept of improved hybrid immunity upon immunization.
  • ||||||||||  fluticasone propionate/salmeterol xinafoate inhalation powder / Generic mfg.
    Enrollment open, Trial completion date, Trial primary completion date, Adverse events:  MAELABA: Mechanisms of Adverse Effects of Long-Acting Beta-Agonists in Asthma (clinicaltrials.gov) -  Apr 25, 2023   
    P4,  N=24, Recruiting, 
    Not yet recruiting --> Recruiting | Trial completion date: May 2028 --> Mar 2033 | Trial primary completion date: Jul 2027 --> Mar 2028 Unknown status --> Recruiting | Trial completion date: Dec 2021 --> Sep 2024 | Trial primary completion date: Mar 2021 --> Sep 2024
  • ||||||||||  Airsupra (budesonide/salbutamol) / AstraZeneca, Avillion
    Journal:  New Combination Asthma Drug. (Pubmed Central) -  Apr 24, 2023   
    Recruiting --> Active, not recruiting | N=478 --> 82 A new asthma drug, Airsupra, combines the short-acting ?2-adrenergic agonist albuterol with the corticosteroid budesonide to treat acute asthma attacks.Patients should not stop their asthma maintenance therapy when albuterol-budesonide is prescribed.
  • ||||||||||  tranexamic acid oral / Generic mfg., fluticasone / Generic mfg., hydroquinone / Generic mfg.
    Cosmetic issues and its nuances in dark skin (Level 3 - Nicoll 1) -  Apr 24, 2023 - Abstract #WCD2023WCD_1621;    
    KEY MESSAGE: In overall treatment of pigmentary disorders, various combinations of oral vitamin C, tranexamic acid, glutathione can be incorporated into daily regime along with sunscreens, topical agents containing combinations of kojic acid, arbutin, vitamin C, niacinamide, glycolic acid and lactic acid. As a multipronged approach 1064 Nano, Pico Nd:Yag, Erbium Yag laser will further reduce the intensity of hyper pigmentation in skin of color
  • ||||||||||  dexamethasone / Generic mfg., tacrolimus topical / Generic mfg.
    Repigmentation of a stubborn vitiligo (Level 3 - Nicoll 1) -  Apr 24, 2023 - Abstract #WCD2023WCD_1315;    
    KEY MESSAGE: Vitiligo is most disfiguring in darker skin types, given the contrast between normal skin and vitiligo patches. However, when well approached, repigmentation responses are easily achievable in skin of color
  • ||||||||||  Tri-Luma (fluocinolone acetonide/hydroquinone/tretinoin) / Galderma
    Thiamidol as an Adjunctive with Triluma for melasma treatment in Asian (Level 3 - Room 310+311) -  Apr 24, 2023 - Abstract #WCD2023WCD_1244;    
    However, when well approached, repigmentation responses are easily achievable in skin of color Sponsored by Beiersdorf
  • ||||||||||  prednisolone / Generic mfg.
    Journal:  Different presentation of autoimmune hepatitis in children: Case series. (Pubmed Central) -  Apr 24, 2023   
    All four cases showed high serum Ig G levels and responded to oral prednisolone only. AIH should be excluded for all patients with symptoms or signs of prolonged, relapsing, or severe liver disease so that treatment can be promptly initiated and morbidity can be reduced.